About 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline
8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline (PubChem CID 170775098) has the molecular formula C27H25ClF2N6O
and a molecular weight of 522.99 g/mol. Its IUPAC name is 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline.
Molecular Properties
| Compound Name | 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline |
| PubChem CID | 170775098 |
| Molecular Formula | C27H25ClF2N6O |
| Molecular Weight | 522.99 g/mol |
| Exact Mass | 522.17 |
| IUPAC Name | 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline |
| SMILES | Cc1nc2ccc(Oc3ccc4ncc(-c5cnn([C@H](C)C6CCC(F)(F)CC6)c5)nc4c3Cl)cc2[nH]1 |
| InChI | InChI=1S/C27H25ClF2N6O/c1-15(17-7-9-27(29,30)10-8-17)36-14-18(12-32-36)23-13-31-21-5-6-24(25(28)26(21)35-23)37-19-3-4-20-22(11-19)34-16(2)33-20/h3-6,11-15,17H,7-10H2,1-2H3,(H,33,34)/t15-/m1/s1 |
| InChIKey | XFICUJRBVVCLBY-OAHLLOKOSA-N |
| XLogP | 7.51 |
| TPSA | 81.51 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 522.99 |
| LogP ≤ 5 | 7.51 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline?
The IUPAC name of 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline (CID 170775098) is 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline.
What is the SMILES notation for 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline?
The canonical SMILES for 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline is Cc1nc2ccc(Oc3ccc4ncc(-c5cnn([C@H](C)C6CCC(F)(F)CC6)c5)nc4c3Cl)cc2[nH]1.
What is the InChIKey of 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline?
The InChIKey is XFICUJRBVVCLBY-OAHLLOKOSA-N. The full InChI is InChI=1S/C27H25ClF2N6O/c1-15(17-7-9-27(29,30)10-8-17)36-14-18(12-32-36)23-13-31-21-5-6-24(25(28)26(21)35-23)37-19-3-4-20-22(11-19)34-16(2)33-20/h3-6,11-15,17H,7-10H2,1-2H3,(H,33,34)/t15-/m1/s1.
What are the key properties of 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline?
8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline has a molecular weight of 522.99 g/mol, XLogP of 7.51, 5 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 8-chloro-2-[1-[(1R)-1-(4,4-difluorocyclohexyl)ethyl]pyrazol-4-yl]-7-[(2-methyl-3H-benzimidazol-5-yl)oxy]quinoxaline is sourced from PubChem (CID 170775098), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).